Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Kelch repeat and BTB domain containing 2 pseudogene (LOC100421674, ENSG00000278346) is classified as a pseudogene, meaning it does not produce a functional protein. It is not considered a protein-coding gene and does not have identified biological function, involvement in disease, or therapeutic relevance[1][4]. Although related protein-coding genes, such as Kelch repeat and BTB domain containing 2 (KBTBD2, ENSG00000170852), are involved in pathways such as ubiquitination and insulin signaling[2][7], the pseudogene in question (ENSG00000278346/LOC100421674) does not encode a functional protein and is not a valid therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kelch repeat and BTB domain containing 2 pseudogene.